Multiple patient samples of an analyte improve detection of changes in clinical status

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 1, 2010, Pages 81-89

  Kroll, Martin H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; BIOLOGICAL MODEL; CONFIDENCE INTERVAL; DISEASE COURSE; HUMAN; PATHOLOGY; PATIENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICS;

ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; PATHOLOGY, CLINICAL; PATIENTS; SENSITIVITY AND SPECIFICITY;

EID: 75149182816     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Winkel P, Statland BE. Using the subject as his own referent in assessing day-to-day changes of laboratory test results. Contemp Topics Anal Clin Chem. 1977;1:287-317.
2. Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998.
3. Bruins S, Fokkema MR, Romer JWP, et al. High intraindividual variation of B-type Natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem. 2004;50:2052-2058.
4. Fraser CG. Biological Variation: From Principles to Practice. Washington, DC: AACC Press; 2001.
5. Trudeau RJ. Introduction to Graph Theory. Mineola, NY: Dover Publications Inc; 1993:19-20.
6. Strang G. Introduction to Applied Mathematics. Wellesley, MA: Wellesley- Cambridge Press; 1986:624-625.
7. Mandel J. The Statistical Analysis of Experimental Data. Mineola, NY: Dover Publications; 1964,1984:63-65.
8. Kroll MH. Biological variation of glucose and insulin includes a deterministic chaotic component. Biosystems. 1999;50:189-201.
9. Burtis CA, Ashwood ER, Bruns DE. Tietz Fundamentals of Clinical Chemistry. 6th ed. St Louis, MO: Saunders Elsevier; 2008.
10. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847.
11. Stamler D, Wentworth Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?: findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
12. Lipid Research Clinic. The Lipid Research Clinics Coronary Primary Prevention Trial results: I: reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
13. Wu AHB. Serial testing of B-type natriuretic peptide and NT-proBNP for monitoring therapy of heart failure: the role of biological variation in the interpretation of results. Am Heart J. 2006;152:828-834.
14. Cournot M, Mourre F, Castel F, Ferrieres J, Destrac S. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure. Am Heart J. 2008;155:986-991.
15. Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Clin Chem. 2009;55:78-84.
16. Tuxen MK, Soletormos G, Rustin GJS, Nelstrop AE, Dombernowsky P. Biological variation and analytical imprecision of CA-125 in patients with ovarian cancer. Scand J Clin Lab Invest. 2000;60:713-721.
17. Kroll MH. Evaluating sequential values using time-adjusted biological variation. Clin Chem Lab Med. 2002;40:499-504
18. Boron W, Boulpaep EL. Medical Physiology. Philadelphia, PA: Saunders Elsevier; 2003.
19. Porksen N, Nyholm B, Veldhuis J, Butler PC, Schmitz O. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am J Physiol. 1997;273:E908-E914.
20. Langley R. Practical Statistics Simply Explained. New York, NY: Dover Publications Inc; 1968:1970.